Catalyst Wire Dossier Catalyst Wire Dossier

TNX-1500

· Tonix Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TNX-1500, covering 2026-02-25 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects [Phase 1]

See pricing